Breaking News

AARDEX and Cambridge Cognition Join Forces to Bring Next-Level Adherence Oversight to Hybrid and Decentralized Clinical Trials

Seamless integration of adherence and research data protects participant safety and data quality, with no additional burden for clinical trial sites or participants Liege, Belgium- February 2, 2023: Adherence specialists AARDEX Group and remote research platform experts in the Clinpal team at Cambridge Cognition have teamed up to provide next-level adherence monitoring during hybrid and decentralized clinical trials (DCTs). Integrating AARDEX Group’s…

Read More

Ask the Medication Adherence Experts: Edition One

Poor medication adherence during clinical trials can skew results, leading to underestimations of product efficacy, inaccurate pharmacokinetic/pharmacodynamic calculations, and even put participant safety at risk.1 Research has shown that up to 50% of people who take part in drug development research do not take their medicines as prescribed.1 Despite this, there remains no systematic approach to…

Read More

Why Near-Perfect Medication Adherence Often Equates to Toxicity.

The World Health Organization (WHO) has recently highlighted how poor adherence can lead to poorer outcomes for prisoners, contributing to health inequalities the world over. But it is worth noting that near-perfect adherence can be just as troublesome within the current drug development landscape.  With medication administration being almost compulsory behind bars, people can fall…

Read More

AARDEX Group and medmix Join Forces to Improve Self-Administration of Injectable Drugs in Clinical Trials

Belgium – medmix Drug Delivery (Haselmeier) and AARDEX Group announced today a collaboration, combining Haselmeier´s D-Flex™ Logbook with AARDEX Group’s Medication Adherence software and hardware ecosystem.  Clinical testing during new drug development is costly and time intensive for pharmaceutical and biotech companies. The need for solutions, helping them to shorten testing time and increase data…

Read More

Clinical Trials Europe 2022: Learn About Unlocking Medication Adherence Insights to Enhance Drug Development

Poor medication adherence in clinical trials may be a long-standing challenge, but advanced approaches and technologies are finally cutting it down to size. Join AARDEX’s scientific lead at the 21st Clinical Trials Europe event to find out how. Bernard Vrijens and Kenneth Getz, Executive Director and Professor at Tufts Center for the Study of Drug Development…

Read More

Measure to Manage: How Data-Driven Feedback Drives up Patient Adherence in Clinical Trials

Every clinical trial participant with poor medication adherence will have their own set of complex reasons for not taking their medications as prescribed – meaning there is no one size fits all solution. Instead, sponsors should take a data-driven approach that utilizes focused feedback, guides individualized interventions, and has been shown to be capable of…

Read More

Setting the Stage for Better Medication Adherence in Clinical Trials

Better medication adherence in clinical trials

When clinical trial participants do not follow the dosing protocol, it can result in an underestimation of a drug’s therapeutic effect. With inability to demonstrate efficacy being the leading cause of study failure worldwide1, it’s an issue sponsors cannot afford to ignore – and with digitally enabled medication adherence packaging, they no longer have to.…

Read More

How Effective Are Digital Pills at Measuring Medication Adherence?

While digital pills have long been hailed as a valuable solution to the stubborn medication adherence problem, there have been questions about their use, in terms of intrusiveness, acceptance, and reliability. But with the evidence base expanding, there are opportunities to embrace the paradigm-shifting potential of this innovative solution. A stubborn challenge It’s no secret…

Read More